Browsing Centre for Biochemical Pharmacology by Author "Gore, R"
Now showing items 1-5 of 5
-
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.
Jackson, DJ; Busby, J; Pfeffer, PE; Menzies-Gow, A; Brown, T; Gore, R; Doherty, M; Mansur, AH; Message, S; Niven, R (BMJ, 2020-12-09)BACKGROUND: The UK Severe Asthma Registry (UKSAR) is the world's largest national severe asthma registry collecting standardised data on referrals to UK specialist services. Novel biologic therapies have transformed the ... -
Ethnic differences in severe asthma clinical care and outcomes: an analysis of United Kingdom primary and specialist care.
Busby, J; Heaney, L; Brown, T; Chaudhuri, R; Dennison, P; Gore, R; Jackson, DJ; Mansur, A; Menzies-Gow, A; Message, S -
Impact of comorbidities on EQ5D quality of life index in severe asthma
Pfeffer, PE; Brown, T; Chaudhuri, R; Faruqi, S; Gore, R; Heaney, L; Mansur, AH; Pantin, T; Patel, M; Rupani, H (Elsevier, 2024-05-31) -
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
Smith, SJ; Busby, J; Heaney, LG; Pfeffer, PE; Jackson, DJ; Yang, F; Fowler, SJ; Menzies-Gow, A; Idris, E; Brown, T (2021-01)Asthma therapy, including monoclonal antibodies, was not associated with #COVID19 infection or hospitalisation in a UK severe asthma population. Shielding led to a reported worsening of mental health in nearly half of ... -
S25 The impact of COVID-19 on the UK severe asthma population
Smith, S; Busby, J; Heaney, L; Pfeffer, P; Jackson, D; Yang, J; Fowler, S; Menzies-Gow, A; Idris, E; Brown, T (BMJ, 2021-02)